Medco Holdings (PHS:MED) 3-Year EBITDA Growth Rate: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PHS:MED Medco Holdings Inc PHS:MED
21 GF Score
Price ₱0.11
View Full Analysis

What is Medco Holdings 3-Year EBITDA Growth Rate?

Medco Holdings PHS:MED 21 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates PHS:MED with a GF Score™ of 21/100. Among 514 Asset Management companies, Medco Holdings ranks worse than 194552.33% on this metric.

Medco Holdings's EBITDA per Share for the three months ended in Mar. 2026 was ₱0.00.

During the past 5 years, the average EBITDA Per Share Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Medco Holdings was 60.80% per year. The lowest was -207.70% per year. And the median was 0.00% per year.

Medco Holdings  (PHS:MED) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Medco Holdings 3-Year EBITDA Growth Rate Related Terms

PHS:MED vs BLK, BX, KKR: 3-Year EBITDA Growth Rate Comparison

For the Asset Management subindustry, Medco Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medco Holdings 3-Year EBITDA Growth Rate vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Medco Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Medco Holdings's 3-Year EBITDA Growth Rate falls into.


PHS:MED
21GF Score
Medco Holdings Inc PHS:MED
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medco Holdings 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Medco Holdings (PHS:MED) has a 3-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Medco Holdings and its competitors. According to the industry distribution chart, Medco Holdings ranks #999999 out of 514 companies in the Asset Management industry.
Is Medco Holdings' 3-Year EBITDA Growth Rate too high?
Medco Holdings' current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Medco Holdings ranks #999999 out of 514 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, Medco Holdings has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Medco Holdings' 3-Year EBITDA Growth Rate compare to BLK and BX?
According to the Asset Management industry distribution chart, Medco Holdings ranks #999999 out of 514 companies for 3-Year EBITDA Growth Rate. This places Medco Holdings in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Asset Management company?
The median 3-Year EBITDA Growth Rate among Asset Management companies is 10.90, based on 514 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Medco Holdings and its competitors. For the Asset Management industry, the median 3-Year EBITDA Growth Rate is 10.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medco Holdings's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medco Holdings stock overvalued right now?
Medco Holdings (PHS:MED) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Medco Holdings' overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Medco Holdings (PHS:MED), the current 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medco Holdings Business Description

Address 6784 Ayala Avenue, 31st Floor, Rufino Pacific Tower, Metro Manila, Makati City, PHL, 1229
Medco Holdings Inc is an investment holding company. The company's investment portfolio is composed of holdings in a company involved in trade development (operation of exhibition halls and conference facilities).
21GF Score

Get the complete analysis for PHS:MED

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱0.11
Price